Haemophilia and Hereditary Angioedema – A Shared Therapeutic Revolution in Rare Diseases – RPTH Journal
RPTH Journal shared a post on LinkedIn about a recent article by Massimo Cugno et al., adding:
“Haemophilia and hereditary angioedema: two rare diseases, one shared therapeutic revolution
Haemophilia and hereditary angioedema (HAE) are both rare monogenic disorders involving dysregulation of serine protease pathways, blood coagulation and the kallikrein–kinin system, respectively.
Their clinical manifestations could not be more different: bleeding vs angioedema.
Yet their therapeutic journeys have evolved in strikingly parallel ways.
A new review Massimo Cugno and Pier Mannuccio Mannucci in RPTH Journal traces this parallel evolution, from plasma-derived products in the 1970s to the cutting edge of gene and RNA-based therapies today.
The therapeutic trajectories of haemophilia and HAE illustrate a broader principle: deep mechanistic understanding of rare diseases can drive the transition from managing acute episodes to achieving long-term disease control, and ultimately, cures.”
Title: Hemophilia and hereditary angioedema: parallel therapeutic advances in genetic diseases of serine protease pathways
Authors: Massimo Cugno, Pier Mannuccio Mannucci
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 22, 2026, 14:45Seyed Mehrab Safdari: Prenatal Diagnosis in Hemophilia – Two Decades of Progress and Remaining Challenges
-
Oct 22, 2026, 14:39Mahmoud Abdelnabi: Evaluating the Evidence on Elevated Lp(a) and VTE Before Clinical Translation
-
Oct 22, 2026, 14:34David McIntosh: Fundamental Flaws in National Blood Systems Are Root Causes of Failure
-
Oct 22, 2026, 14:32Aurelio Maggio: Bridging Scientific Progress and Equitable Access to SCD Care in Sub-Saharan Africa
-
Oct 22, 2026, 14:26Khaled Musallam: Longevity and Healthy Aging in Thalassemia
-
Oct 22, 2026, 14:26Deise Catamo Vaz: Two Years of Growth and a New Way of Seeing the World of Stroke
-
Oct 22, 2026, 14:24Yara Mohamed: A Silent Killer Plots his Victim’s Death Over Years
-
Oct 22, 2026, 14:19Shailendra Singh: Two Different Pulmonary Embolism Cases, One Critically Important Lesson
-
Oct 22, 2026, 14:14Caitlin Raymond: Estimating Infection Rates After Therapeutic Plasma Exchange in a Large Real-World Population